$Assembly Biosciences Inc.(ASMB)$ Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733 Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023 Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024 SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting seri

Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities

Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53. Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks. Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75. The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves followin

$Assembly Biosciences Inc.(ASMB)$要往毛票走了[喷血] 

$Assembly Biosciences Inc.(ASMB)$有没有20年拿到现在的？

$纳斯达克(.IXIC)$今晚扑街

$标普500(.SPX)$2100

$道琼斯(.DJI)$16000

$纳斯达克(.IXIC)$8000

$德意志银行(DB)$这股票怎么连跌十来年…

$纳斯达克(.IXIC)$今晚扑街

$NQ100指数主连 2209(NQmain)$今晚扑街

$Assembly Biosciences Inc.(ASMB)$Infectious disease has definitely been on everyone’s radar for the past couple of years. And while corona made the headlines, it’s hardly the only serious pathogen out there. Hepatitis B virus (HBV) has long been known as a serious public health matter. The virus causes chronic, progressive, and severe liver disease, and while vaccines can prevent infection and transmission, there are few fully effective treatments available for patients suffering with the disease. Assembly Biosciences aims to change that situation.The company has an active research pipeline, featuring no fewer than three core inhibitor drug candidates. This is a new class of drugs, designed to interfere with the virus life cycle by blocking the virus

$Assembly Biosciences Inc.(ASMB)$往破产弄，加油💪

$Assembly Biosciences Inc.(ASMB)$SOUTH SAN FRANCISCO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and other viral diseases, today announced grants of stock options to two new employees to purchase an aggregate of 7,000 shares of the Company’s common stock with an exercise price of $2.45 per share, the closing price of Assembly Bio’s common stock on January 3, 2022. The stock options were granted as material inducements to the new employees to accept the Company’s offers of employment.The stock options have a ten-year term and vest over four years, with one-fourth vesting on the first anniversary of the d

$Assembly Biosciences Inc.(ASMB)$应该要往一块走了[看跌] 

$Assembly Biosciences Inc.(ASMB)$我想问一下这个现在是是不是属于中概股？[晕] 

$Assembly Biosciences Inc.(ASMB)$别墨迹了直接到毛票吧准备好了。

$Assembly Biosciences Inc.(ASMB)$很奇怪，我发现只要我一发看涨的帖就跌…  难道是庄家在抓心理？           回本之前不再发任何这只股票的贴了。

$Assembly Biosciences Inc.(ASMB)$麻了